Certain death in uncertain time: a qualitative study of the experience of advanced ovarian cancer.
Certain death in uncertain time: a qualitative study of the experience of advanced ovarian cancer.
批准号:
nhmrc : 402601
负责人:
A/Pr Christopher Jordens
金额:
$14.79万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Modern medicine aims to find effective treatments for life-threatening diseases. Cures are seldom found, however. More typically, rapidly fatal diseases gradually become less rapidly fatal. Consequently, there is a category of patients who are certain they will die from their disease or a related factor, but who are equally uncertain as to whether they have weeks or years left to live. It is difficult to discuss this predicament because we do not even have a name for it, let alone a useful terminology to describe it. The absence of discussion exacerbates patients' social isolation. Also, the quality of their remaining life, and the quality of the care they get, depends heavily on the quality of understanding and communication within the social systems that support them. A growing proportion of patients in developed countries fall into this category, including the 1200 Australian women who are diagnosed each year with advanced ovarian cancer. This study aims to increase our understanding of the experience of certain death in uncertain time by recruiting a group of 20 women with advanced ovarian cancer, and interviewing them every few months over three years. The study will explore all aspects of the experience of having advanced ovarian cancer, and generate a terminology for it - one that grows out of the women's own language. The study will inform the organisation and delivery of clinical care and services to women with ovarian cancer. It will also inform patient education programs, and help to tune medical education to the particular needs and perceptions of patients who are experiencing the certainty of death in uncertain time. Finally, the researchers will also explore the implications of the findings for medical ethics and health law, and for communication, information and decision-making in cancer medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Calling the tune? Investigating corporate influences on media reporting of health
-
批准号:nhmrc : 632840
-
项目类别:NHMRC Project Grants
-
资助金额:$30.81万
-
财政年份:2010
-
负责人:A/Pr Christopher Jordens
-
依托单位:
Ethical and legal issues surrounding the decision-making process for donating and banking Umbilical Cord Blood
-
批准号:nhmrc : 512416
-
项目类别:NHMRC Project Grants
-
资助金额:$27.84万
-
财政年份:2008
-
负责人:A/Pr Christopher Jordens
-
依托单位:
Deconstructing DTCA: Towards a differentiated policy response to Direct-to-Consumer Advertising in Australia.
-
批准号:nhmrc : 457497
-
项目类别:NHMRC Project Grants
-
资助金额:$12.72万
-
财政年份:2007
-
负责人:A/Pr Christopher Jordens
-
依托单位:
Difficult decisions: a critical analysis of consent to high-risk medical procedures
-
批准号:nhmrc : 457439
-
项目类别:NHMRC Project Grants
-
资助金额:$21.4万
-
财政年份:2007
-
负责人:A/Pr Christopher Jordens
-
依托单位:
国内基金
海外基金
登录
查看更多内容
亚麻LuMOD1(mosaic death 1)基因调控种子大小的分子机理研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:江海霞
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
METTL7B通过m6A甲基化GPX4抑制非小细胞肺癌细胞铁死亡的机制研究
-
批准号:32100609
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:宋惠彬
-
依托单位:
褪黑素促进MCL-1抑制剂诱导白血病细胞凋亡的分子机制研究
-
批准号:32100607
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:叶开琴
-
依托单位:
PIR蛋白通过抑制Fas介导的凋亡信号通路促进结肠癌发生的机理
-
批准号:32100601
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:马欢欢
-
依托单位:
Tousled like kinase介导青光眼中视网膜神经节细胞死亡的作用和机制
-
批准号:32000518
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2020
-
负责人:赵春月
-
依托单位:
ATM激酶介导NCOA4磷酸化参与铁死亡调节的研究
-
批准号:32070738
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:吴浩
-
依托单位:
流感病毒感染T淋巴细胞并致感染细胞异常死亡机制研究
-
批准号:81970010
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2019
-
负责人:曹彬
-
依托单位:
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
-
批准号:31970688
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:章海兵
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位: